Sunitinib Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Previously Treated Advanced Non―Small-Cell Lung Cancer: A Phase III TrialSCAGLIOTTI, Giorgio V; KRZAKOWSKI, Maciej; PAPAI, Zsolt S et al.Journal of clinical oncology. 2012, Vol 30, Num 17, pp 2070-2078, issn 0732-183X, 9 p.Article

A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid TumorsSWEENEY, Christopher J; CHIOREAN, E. Gabriela; BURRIS, Howard A et al.Journal of clinical oncology. 2010, Vol 28, Num 29, pp 4513-4520, issn 0732-183X, 8 p.Article

Multicenter, Phase II Trial of Sunitinib in Previously Treated, Advanced Non-Small-Cell Lung CancerSOCINSKI, Mark A; NOVELLA, Silvia; TYE, Lesley et al.Journal of clinical oncology. 2008, Vol 26, Num 4, pp 650-656, issn 0732-183X, 7 p.Article

Sunitinib in combination with docetaxel in patients with advanced solid tumors: a phase I dose-escalation studyROBERT, Francisco; SANDLER, Alan; TRAYNOR, Anne M et al.Cancer chemotherapy and pharmacology. 2010, Vol 66, Num 4, pp 669-680, issn 0344-5704, 12 p.Article

Activity of Sunitinib in Patients With Advanced Neuroendocrine TumorsKULKE, Matthew H; LENZ, Heinz-Josef; LI, Jim Z et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3403-3410, issn 0732-183X, 8 p.Article

Crizotinib in ROS1-Rearranged Non―Small-Cell Lung CancerSHAW, Alice T; OU, Sai-Hong I; DOEBELE, Robert C et al.The New England journal of medicine. 2014, Vol 371, Num 21, pp 1963-1971, issn 0028-4793, 9 p.Article